Statistics for Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Total visits

views
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction 14

Total visits per month

views
June 2025 0
July 2025 0
August 2025 0
September 2025 0
October 2025 0
November 2025 0
December 2025 0

File Visits

views
Pembrolizumab in Combination with Neoadjuvant.pdf 66

Top country views

views
Chile 14

Top city views

views
Santiago 14